Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hahn

Showing results (1141-1150 of 1,198) with videos related to

Pageof 120
Sort By:
European Urology|August 21, 2020
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerRussell E N Becker, Alexa R Meyer, Aaron Brant, et al.
JAMA Network Open|January 16, 2019
Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerEric D Brooks, Bing Sun, Lei Feng, et al.
JAMA Oncology|August 18, 2017
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label StudyThomas Powles, Peter H O'Donnell, Christophe Massard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2018
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung CancerZhongxing Liao, J Jack Lee, Ritsuko Komaki, et al.
Cancer|December 21, 2018
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genesPetros Grivas, Amir Mortazavi, Joel Picus, et al.
Journal of Surgical Oncology|June 27, 2020
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicityBrian C Baumann, Karen De Amorim Bernstein, Thomas F DeLaney, et al.
Clinical Genitourinary Cancer|January 1, 2018
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder CancerLauren C Harshman, Abhishek Tripathi, Matthew Kaag, et al.
European Urology|October 4, 2025
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the BladderAmanda A Myers, Ruchika Talwar, Zhigang Duan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Technology for Innovation in Radiation OncologyIndrin J Chetty, Mary K Martel, David A Jaffray, et al.
ESMO Open|April 18, 2024
The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysisD Dannehl, D Jakob, F Mergel, et al.
Pageof 120

Showing results (1141-1150 of 1,198) with videos related to

Sort By:
Pageof 120
European Urology|August 21, 2020
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerRussell E N Becker, Alexa R Meyer, Aaron Brant, et al.
JAMA Network Open|January 16, 2019
Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung CancerEric D Brooks, Bing Sun, Lei Feng, et al.
JAMA Oncology|August 18, 2017
Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label StudyThomas Powles, Peter H O'Donnell, Christophe Massard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2018
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung CancerZhongxing Liao, J Jack Lee, Ritsuko Komaki, et al.
Cancer|December 21, 2018
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genesPetros Grivas, Amir Mortazavi, Joel Picus, et al.
Journal of Surgical Oncology|June 27, 2020
Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicityBrian C Baumann, Karen De Amorim Bernstein, Thomas F DeLaney, et al.
Clinical Genitourinary Cancer|January 1, 2018
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder CancerLauren C Harshman, Abhishek Tripathi, Matthew Kaag, et al.
European Urology|October 4, 2025
Cost-effectiveness Analysis of Treatments for Bacillus Calmette-Guérin-unresponsive Carcinoma in Situ of the BladderAmanda A Myers, Ruchika Talwar, Zhigang Duan, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Technology for Innovation in Radiation OncologyIndrin J Chetty, Mary K Martel, David A Jaffray, et al.
ESMO Open|April 18, 2024
The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysisD Dannehl, D Jakob, F Mergel, et al.
Pageof 120